| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.19 | 0.07 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.06 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.3 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.2 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.007 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.2 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.2 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.5 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |